A detailed history of Peregrine Capital Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Peregrine Capital Management LLC holds 764,218 shares of EXAS stock, worth $37.7 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
764,218
Previous 768,640 0.58%
Holding current value
$37.7 Million
Previous $32.5 Million 60.23%
% of portfolio
1.63%
Previous 0.98%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$42.43 - $70.83 $187,625 - $313,210
-4,422 Reduced 0.58%
764,218 $52 Million
Q2 2024

Jul 29, 2024

BUY
$41.33 - $74.26 $4.71 Million - $8.47 Million
114,047 Added 17.42%
768,640 $32.5 Million
Q1 2024

Apr 26, 2024

SELL
$56.27 - $73.77 $231,269 - $303,194
-4,110 Reduced 0.62%
654,593 $45.2 Million
Q4 2023

Jan 26, 2024

BUY
$59.06 - $75.72 $5.72 Million - $7.33 Million
96,778 Added 17.22%
658,703 $48.7 Million
Q3 2023

Oct 19, 2023

SELL
$65.94 - $99.04 $37,124 - $55,759
-563 Reduced 0.1%
561,925 $38.3 Million
Q2 2023

Jul 26, 2023

SELL
$62.68 - $95.05 $376,644 - $571,155
-6,009 Reduced 1.06%
562,488 $52.8 Million
Q1 2023

Apr 26, 2023

SELL
$47.19 - $70.77 $1.74 Million - $2.62 Million
-36,959 Reduced 6.1%
568,497 $38.5 Million
Q4 2022

Jan 10, 2023

BUY
$30.35 - $53.15 $5.02 Million - $8.79 Million
165,439 Added 37.6%
605,456 $30 Million
Q3 2022

Oct 26, 2022

SELL
$31.97 - $49.37 $189,933 - $293,307
-5,941 Reduced 1.33%
440,017 $14.3 Million
Q2 2022

Jul 20, 2022

SELL
$35.61 - $76.23 $821,095 - $1.76 Million
-23,058 Reduced 4.92%
445,958 $17.6 Million
Q1 2022

Apr 27, 2022

SELL
$57.56 - $82.54 $2.44 Million - $3.49 Million
-42,323 Reduced 8.28%
469,016 $32.8 Million
Q4 2021

Jan 31, 2022

BUY
$72.5 - $100.68 $9.6 Million - $13.3 Million
132,382 Added 34.93%
511,339 $39.8 Million
Q3 2021

Nov 02, 2021

BUY
$90.24 - $124.05 $2.84 Million - $3.91 Million
31,501 Added 9.07%
378,957 $36.2 Million
Q2 2021

Aug 03, 2021

BUY
$93.66 - $139.27 $4.08 Million - $6.06 Million
43,521 Added 14.32%
347,456 $43.2 Million
Q1 2021

May 11, 2021

BUY
$116.57 - $155.01 $2.52 Million - $3.35 Million
21,595 Added 7.65%
303,935 $40.1 Million
Q4 2020

Jan 19, 2021

BUY
$99.61 - $142.12 $3.92 Million - $5.6 Million
39,371 Added 16.2%
282,340 $37.4 Million
Q3 2020

Oct 20, 2020

BUY
$72.92 - $102.01 $17.7 Million - $24.8 Million
242,969 New
242,969 $24.8 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.